Adaptation and Cost-Effectiveness Analysis of the "My Health Everyday" Medication Adherence Coaching Application for Hypertension Management in Hungary

Author(s)

Kárász D1, Erdősi D2, Kardas P3, Lewek P3, Klimczak P3, Łojewska E4, Kovács S5, Zemplenyi A6, Agh T7
1Faculty of Pharmacy, University of Pécs, Pécs, BA, Hungary, 2Center for Health Technology Assessment and Pharmacoeconomic Research, University of Pécs, Pécs, Hungary, 3Medication Adherence Research Centre, Department of Family Medicine, Medical University of Lodz, Lodz, Poland, 4International Projects Department, Medical University of Lodz, Lodz, Poland, 51) Center for Health Technology Assessment and Pharmacoeconomic Research, University of Pécs, Pécs, Hungary 2) Syreon Research Institute, Budapest, Hungary, 6Center for Health Technology Assessment and Pharmacoeconomic Research, University of Pécs, Aurora, CO, USA, 71) Center for Health Technology Assessment and Pharmacoeconomic Research, University of Pécs, Pécs, Hungary 2) Syreon Research Institute, Budapest, PE, Hungary

OBJECTIVES: This study aimed to adapt the "My Health Everyday" medication adherence coaching application, originally developed in Poland, for use in Hungary; and to evaluate the cost-effectiveness of the adapted application compared to usual care among adults with hypertension, considering the perspective of the Hungarian healthcare payer.

METHODS: The study, conducted from January to June 2023, involved a 5-step translation process of the application: Polish to English translation, English to Hungarian translation, expert panel review, patient pre-testing, and final iteration. A decision-analytic Markov cohort model with a 12-month time horizon was developed, utilizing literature-based model parameters. The application was estimated to improve medication adherence to anti-hypertensives by 20%. The primary outcome measure was the incremental cost-effectiveness ratio (ICER) and one way deterministic analysis was conducted to examine parameter uncertainty. Additionally, the study considered the estimation of the value-based price of the application, taking into account the Hungarian cost-effectiveness threshold.

RESULTS: Translation challenges emerged due to differences between the Polish and Hungarian healthcare systems, medical terminology, and other cross-cultural aspects. The Hungarian version of the application consisted of 72 patient advice items (Polish version had 79 items). Assuming the cost of the application to be “free”, the ICER analysis demonstrated the coaching application's dominance over usual care. Patients with improved adherence achieved an estimated gain of 0.0001 quality-adjusted life years (QALYs) over 12 months. In a population of 1,000 patients, the application was projected to prevent 1.8 cases of stroke, coronary heart disease, or heart failure, along with 0.2 deaths.

CONCLUSIONS: The adapted medication adherence coaching application holds promise for enhancing hypertension management in Hungary. Our findings underscore the importance of cross-cultural and conceptual adaptation when introducing healthcare applications across different countries. Furthermore, evaluating cost-effectiveness prior to implementation is crucial for informed decision-making.

Conference/Value in Health Info

2023-11, ISPOR Europe 2023, Copenhagen, Denmark

Value in Health, Volume 26, Issue 11, S2 (December 2023)

Code

MT34

Topic

Economic Evaluation, Medical Technologies, Patient-Centered Research

Topic Subcategory

Adherence, Persistence, & Compliance, Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Cardiovascular Disorders (including MI, Stroke, Circulatory), No Additional Disease & Conditions/Specialized Treatment Areas

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×